Existence of an Endogenous Circadian Blood Pressure Rhythm in Humans That Peaks in the Evening

Rationale: Blood pressure (BP) usually decreases during nocturnal sleep and increases during daytime activities. Whether the endogenous circadian control system contributes to this daily BP variation has not been determined under appropriately controlled conditions. Objective: To determine whether there exists an endogenous circadian rhythm of BP in humans. Methods and Results: In 28 normotensive adults (16 men), we assessed BP across 3 complementary, multiday, in-laboratory protocols performed in dim light, throughout which behavioral and environmental influences were controlled and/or uniformly distributed across the circadian cycle via: (1) a 38-hour “constant routine,” including continuous wakefulness; (2) a 196-hour “forced desynchrony” with 7 recurring 28-hour sleep/wake cycles; and (3) a 240-hour forced desynchrony with 12 recurring 20-hour sleep/wake cycles. Circadian phases were derived from core body temperature. Each protocol revealed significant circadian rhythms in systolic and diastolic BP, with almost identical rhythm profiles among protocols. The peak-to-trough amplitudes were 3 to 6 mm Hg for systolic BP and 2 to 3 mm Hg for diastolic BP (always P<0.05). All 6 peaks (systolic and diastolic BP in 3 protocols) occurred at a circadian phase corresponding to ≈9:00 PM (ie, the biological evening). Based on substantial phase differences among circadian rhythms of BP and other variables, the rhythm in BP appeared to be unrelated to circadian rhythms in cortisol, catecholamines, cardiac vagal modulation, heart rate, or urine flow. Conclusions: There exists a robust endogenous circadian rhythm in BP. The highest BP occurred at the circadian time corresponding to ≈9:00 PM, suggesting that the endogenous BP rhythm is unlikely to underlie the well-documented morning peak in adverse cardiovascular events.

[1]  F. Scheer,et al.  Endogenous Circadian Rhythm in Vasovagal Response to Head-Up Tilt , 2011, Circulation.

[2]  F. Scheer,et al.  Impact of the human circadian system, exercise, and their interaction on cardiovascular function , 2010, Proceedings of the National Academy of Sciences.

[3]  J. Dyck,et al.  Short Communication: Ischemia/Reperfusion Tolerance Is Time-of-Day–Dependent: Mediation by the Cardiomyocyte Circadian Clock , 2009, Circulation research.

[4]  M. Sole,et al.  Molecular Time: An Often Overlooked Dimension to Cardiovascular Disease , 2009, Circulation research.

[5]  A. Valipour,et al.  Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study. , 2009, British journal of clinical pharmacology.

[6]  G. Reed,et al.  Vascular Disease in Mice With a Dysfunctional Circadian Clock , 2009, Circulation.

[7]  F. Scheer,et al.  Adverse metabolic and cardiovascular consequences of circadian misalignment , 2009, Proceedings of the National Academy of Sciences.

[8]  J. Staessen,et al.  Night–day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension , 2009, Journal of Human Hypertension.

[9]  H. Stanley,et al.  Endogenous circadian rhythm in human motor activity uncoupled from circadian influences on cardiac dynamics , 2007, Proceedings of the National Academy of Sciences.

[10]  Tom S. Price,et al.  Circadian variation of blood pressure and the vascular response to asynchronous stress , 2007, Proceedings of the National Academy of Sciences.

[11]  F. Scheer,et al.  SCN Outputs and the Hypothalamic Balance of Life , 2006, Journal of biological rhythms.

[12]  M. Hilton,et al.  Independent circadian and sleep/wake regulation of adipokines and glucose in humans. , 2005, The Journal of clinical endocrinology and metabolism.

[13]  F. Scheer,et al.  Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension , 2004, Hypertension.

[14]  R. Hermida,et al.  Circadian Time-Qualified Tolerance Intervals for Ambulatory Blood Pressure Monitoring in the Diagnosis of Hypertension , 2004, Chronobiology international.

[15]  F. Scheer,et al.  Cardiovascular Control by the Suprachiasmatic Nucleus: Neural and Neuroendocrine Mechanisms in Human and Rat , 2003, Biological chemistry.

[16]  H. V. Van Dongen,et al.  REPEATED ASSESSMENT OF THE ENDOGENOUS 24-HOUR PROFILE OF BLOOD PRESSURE UNDER CONSTANT ROUTINE* , 2001, Chronobiology international.

[17]  W. White,et al.  Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics , 2000, Contemporary Cardiology.

[18]  R. Kronauer,et al.  Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression , 2000, The Journal of physiology.

[19]  R. Kronauer,et al.  Stability, precision, and near-24-hour period of the human circadian pacemaker. , 1999, Science.

[20]  A. C. Bobbert,et al.  Absence of endogenous circadian rhythmicity in blood pressure? , 1998, American journal of hypertension.

[21]  J. Vestbo,et al.  Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. , 1995, Journal of human hypertension.

[22]  B. Janssen,et al.  Suprachiasmatic lesions eliminate 24-h blood pressure variability in rats , 1994, Physiology & Behavior.

[23]  F. Davis,et al.  Transplanted suprachiasmatic nucleus determines circadian period. , 1990, Science.

[24]  Daniel B Hier,et al.  Morning increase in onset of ischemic stroke. , 1989, Stroke.

[25]  E. Braunwald,et al.  Circadian variation in the frequency of onset of acute myocardial infarction. , 1985, The New England journal of medicine.

[26]  J. Laragh,et al.  Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. , 1982, JAMA.

[27]  M. Hilton,et al.  Day/Night Pattern of Myocardial Infarction and Sudden Cardiac Death , 2007 .

[28]  F. Portaluppi,et al.  The rhythms of blood pressure in humans. Exogenous and endogenous components and implications for diagnosis and treatment. , 1996, Annals of the New York Academy of Sciences.